June 14, 2023 Experience Cutia Therapeutics HK$412.9 million IPO We advised Cutia on its IPO and HKEX listing
June 6, 2023 Experience Metropolis of Tokyo $500 million bond offering We advised the Tokyo Metropolitan Government on the transaction
May 17, 2023 Experience Forbion European Acquisition combination with enGene We are advising Forbion European Acquisition on its de-SPAC transaction
May 17, 2023 Experience Honeywell €1.15 billion senior notes offering The investment-grade notes are due 2027 and 2032
May 17, 2023 Experience Honeywell $1.75 billion senior notes offering The investment-grade notes are due 2029 and 2034
May 3, 2023 Experience Anglo American $900 million notes offering The 5.500% senior notes are due 2033
April 28, 2023 Experience MedSci Healthcare Holdings HK$608 million IPO We advised MedSci on its IPO and HKEX listing